• Something wrong with this record ?

Post-enucleation socket syndrome-a novel pathophysiological definition

AC. Rokohl, A. Kopecky, M. Trester, PA. Wawer Matos, KR. Pine, LM. Heindl

. 2022 ; 260 (8) : 2427-2431. [pub] 20220402

Language English Country Germany

Document type Journal Article, Review

E-resources Online Full text

NLK ProQuest Central from 1997-10-01 to 1 year ago
Medline Complete (EBSCOhost) from 2009-07-01 to 1 year ago
Health & Medicine (ProQuest) from 1997-10-01 to 1 year ago

BACKGROUND: The last definition of the post-enucleation socket syndrome (PESS) by Tyers and Collin-formulated almost 40 years ago in 1982-is predominantly based on the clinical characteristics and does not include the insights of newer studies into the pathophysiological mechanism of the PESS. METHODS: A systematic PubMed literature review regarding the pathophysiological mechanism of the PESS was performed, and results were comprised to give an overview of the current knowledge of the PESS including the exact pathophysiological mechanism. RESULTS: The primarily postulated pathophysiological mechanism of the PESS was the atrophy of orbital tissues, especially of fat, resulting in variable clinical findings. Newer studies using high-resolution computed tomography and magnetic resonance imaging or performing histopathological analyses found no orbital fat atrophy but rather a rotatory displacement of the orbital tissues from superior to posterior and from posterior to inferior together with the retraction of the extraocular muscles and a possible volume loss of the orbital implant by resorption if it is manufactured from hydroxyapatite. PESS results in a backward tilt of the superior fornix, a deep superior sulcus, a pseudo-ptosis, a lower eyelid elongation and laxity, a shallower inferior fornix, as well as enophthalmos and may lead to an inability of wearing ocular prostheses. CONCLUSIONS: A novel and comprehensive definition of the PESS is proposed: PESS is a multifactorial and variable syndrome caused by a rotatory displacement of orbital contents together with the retraction of the extraocular muscles and possible resorption of the orbital implant if it is manufactured from hydroxyapatite.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22025032
003      
CZ-PrNML
005      
20221031100338.0
007      
ta
008      
221017s2022 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00417-022-05648-z $2 doi
035    __
$a (PubMed)35366081
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Rokohl, Alexander C $u Department of Ophthalmology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Kerpener Straße 62, 50924, Cologne, Germany. alexander.rokohl@uk-koeln.de $u Center for Integrated Oncology (CIO), Aachen-Bonn-Cologne-Dusseldorf, Cologne, Germany. alexander.rokohl@uk-koeln.de
245    10
$a Post-enucleation socket syndrome-a novel pathophysiological definition / $c AC. Rokohl, A. Kopecky, M. Trester, PA. Wawer Matos, KR. Pine, LM. Heindl
520    9_
$a BACKGROUND: The last definition of the post-enucleation socket syndrome (PESS) by Tyers and Collin-formulated almost 40 years ago in 1982-is predominantly based on the clinical characteristics and does not include the insights of newer studies into the pathophysiological mechanism of the PESS. METHODS: A systematic PubMed literature review regarding the pathophysiological mechanism of the PESS was performed, and results were comprised to give an overview of the current knowledge of the PESS including the exact pathophysiological mechanism. RESULTS: The primarily postulated pathophysiological mechanism of the PESS was the atrophy of orbital tissues, especially of fat, resulting in variable clinical findings. Newer studies using high-resolution computed tomography and magnetic resonance imaging or performing histopathological analyses found no orbital fat atrophy but rather a rotatory displacement of the orbital tissues from superior to posterior and from posterior to inferior together with the retraction of the extraocular muscles and a possible volume loss of the orbital implant by resorption if it is manufactured from hydroxyapatite. PESS results in a backward tilt of the superior fornix, a deep superior sulcus, a pseudo-ptosis, a lower eyelid elongation and laxity, a shallower inferior fornix, as well as enophthalmos and may lead to an inability of wearing ocular prostheses. CONCLUSIONS: A novel and comprehensive definition of the PESS is proposed: PESS is a multifactorial and variable syndrome caused by a rotatory displacement of orbital contents together with the retraction of the extraocular muscles and possible resorption of the orbital implant if it is manufactured from hydroxyapatite.
650    _2
$a atrofie $7 D001284
650    _2
$a enukleace oka $7 D015353
650    _2
$a oční protézy $x škodlivé účinky $7 D005137
650    _2
$a lidé $7 D006801
650    _2
$a hydroxyapatity $7 D006882
650    12
$a nemoci orbity $x diagnóza $x etiologie $x chirurgie $7 D009916
650    12
$a orbitální implantáty $x škodlivé účinky $7 D020273
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Kopecky, Adam $u Ophthalmology Clinic, University Hospital Ostrava, Ostrava, Czech Republic $u Department of Craniofacial Surgery, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
700    1_
$a Trester, Marc $u Trester-Institute for Ocular Prosthetics and Artificial Eyes, Cologne, Germany
700    1_
$a Wawer Matos, Philomena A $u Department of Ophthalmology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Kerpener Straße 62, 50924, Cologne, Germany $u Center for Integrated Oncology (CIO), Aachen-Bonn-Cologne-Dusseldorf, Cologne, Germany
700    1_
$a Pine, Keith R $u School of Optometry and Vision Science, University of Auckland, Auckland, New Zealand
700    1_
$a Heindl, Ludwig M $u Department of Ophthalmology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Kerpener Straße 62, 50924, Cologne, Germany $u Center for Integrated Oncology (CIO), Aachen-Bonn-Cologne-Dusseldorf, Cologne, Germany
773    0_
$w MED00001940 $t Graefe's archive for clinical and experimental ophthalmology $x 1435-702X $g Roč. 260, č. 8 (2022), s. 2427-2431
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35366081 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100336 $b ABA008
999    __
$a ok $b bmc $g 1854635 $s 1176322
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 260 $c 8 $d 2427-2431 $e 20220402 $i 1435-702X $m Graefe's archive for clinical and experimental ophthalmology $n Graefes Arch Clin Exp Ophthalmol $x MED00001940
LZP    __
$a Pubmed-20221017

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...